FDA Drug recall D-1350-2014
Cefpodoxime Proxetil Tablets, USP, 200 mg, 20 Tablet Bottles, Rx Only
- FDA Drug
- Class II
- terminated
- Published 2014-06-04
On 2014-06-04 the FDA classified a Class II recall of Cefpodoxime Proxetil Tablets, USP, 200 mg, 20 Tablet Bottles, Rx Only by Sandoz, citing presence of Foreign Substance: Presence of stainless steel particles.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1350-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-05-22 |
| Published | 2014-06-04 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Sandoz |
| Distribution | US |
Product
Cefpodoxime Proxetil Tablets, USP, 200 mg, 20 Tablet Bottles, Rx Only. Manufactured in Austria by Sandoz GmbH for Sandoz Inc. Princeton, NJ 08540. NDC 0781-5439-20.
Reason
Presence of Foreign Substance: Presence of stainless steel particles.
Identifiers
| ndc | 0781-5438-20 |
|---|---|
| ndc | 0781-5438-01 |
| ndc | 0781-5439-20 |
| ndc | 0781-5439-01 |
| code_info | Lot #: DZ4056, Expiry: 11/2015; Lot # DZ4057, Expiry: 01/2016 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1350-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.